Breast cancer treatment in Istanbul, Turkey
Breast cancer treatment is highly personalized — it is chosen by stage and, critically, by receptor testing. Surgery is either a breast-conserving lumpectomy or a mastectomy, usually with a sentinel lymph node biopsy, and radiation often follows a lumpectomy. The drug plan is decided by the tumour’s ER/PR and HER2 status: chemotherapy, HER2-targeted therapy for HER2-positive tumours, and hormone (endocrine) therapy for ER/PR-positive tumours. Istanbul hospitals offer this full pathway, often at JCI-accredited, state-authorized centers and well below Western-European prices for the same protocol. Every price we show is an illustrative placeholder until verified partner-hospital quotes exist — and you pay the hospital directly, never us. Start with a free 72-hour review of your reports before you decide anything.
Anatomy of the breast and axilla, showing the pectoral muscle, breast lobules and fatty tissue, and the axillary lymph nodes.
SEER Training Modules (Summary Staging Guide 1977), U.S. National Cancer Institute — public domain (opens in a new tab) ↗What breast cancer is
The U.S. National Cancer Institute describes breast cancer as cancer that forms in the tissues of the breast, most often in the ducts that carry milk to the nipple or the lobules that produce it. It is the most common cancer in women, and can also occur in men. The NCI lists increasing age, inherited changes in genes such as BRCA1 and BRCA2, a family or personal history of breast disease, dense breast tissue, and certain hormonal and lifestyle factors among the risks.
Diagnosis usually involves imaging (mammography and ultrasound, often MRI) and a needle biopsy, and the extent of disease is worked out with further imaging and an assessment of the lymph nodes. Crucially, the biopsy tissue is tested for estrogen and progesterone receptors (ER/PR) and HER2 status — results that define the tumour subtype and drive almost every later decision. Inherited-risk cases may also warrant genetic testing. Browse the wider cancer types hub for related diagnoses.
Treatment options
The modalities the NCI lists for breast cancer, and an honest note on each:
- Surgery. Either a breast-conserving lumpectomy — removing the tumour and a rim of normal tissue while keeping the breast — or a mastectomy that removes the whole breast, typically with a sentinel lymph node biopsy or a fuller axillary dissection to check the nodes. Reconstruction options can often be discussed either way.
- Radiation therapy. Commonly given after a lumpectomy to lower the chance the cancer returns in the breast, and after some mastectomies depending on tumour size and node status. Whether it applies depends on your stage and the surgical findings.
- Systemic drug therapy. Chemotherapy where the risk warrants it; HER2-targeted therapy such as trastuzumab (and others) for HER2-positive tumours; and hormone (endocrine) therapy such as tamoxifen or an aromatase inhibitor for ER/PR-positive tumours. Immunotherapy and PARP inhibitors are used for specific subtypes such as triple-negative or BRCA-mutated disease. Which of these applies is decided by your receptor testing, not a template.
- Receptor testing drives everything. The ER/PR and HER2 results are not a formality — they decide whether you receive hormone therapy, HER2-targeted therapy, or chemotherapy alone. A case review confirms whether this testing is already complete on your reports before any plan is built.
See how these modalities work in general on the treatments & technology hub.
What it costs
There is no single breast-cancer price, because the cost is driven by the type of surgery (lumpectomy versus mastectomy, and whether reconstruction is done), whether radiation is used, the number of chemotherapy cycles, and whether HER2-targeted drugs or long-course hormone therapy are added — the targeted drugs are priced per cycle and can dominate the total. Every figure OncologyIstanbul™ publishes today is an illustrative placeholder pending verified partner-hospital quotes, and each is itemized so you can hold a real quote up against it line by line — and you pay the hospital directly, never us. See the Turkey Oncology Price Index or the full cancer treatment cost in Turkey breakdown.
The hospital, verified
We don’t show a wall of smiling surgeons or a “ranked” list — those are the easiest things to fabricate. Instead, you’re matched to one state-authorized Istanbul partner hospital whose breast surgical and medical oncology subspecialty fits your diagnosis, and you can verify its authorization against the Republic of Turkey Ministry of Health’s own records and its JCI accreditation in JCI’s public directory before you commit. Named specialist profiles appear only when a verified, consented physician is behind the name. See the full guide to cancer hospitals in Istanbul and how to check one yourself.
Where this fits
This is one diagnosis within the broader cancer treatment in Istanbul pillar. Because a breast-cancer plan lives or dies on complete receptor testing, if you want your own reports read first, a free second opinion organizes and verifies your pathology and imaging — including whether ER/PR and HER2 status is on file — into a plain-language case file in your language before you decide whether to travel.
You might also look at
Check everything here — us included
Common questions
Can I get breast cancer treatment in Turkey?
Yes. Istanbul hospitals provide the full breast-cancer pathway the U.S. National Cancer Institute describes — breast-conserving surgery (lumpectomy) or mastectomy with sentinel lymph node biopsy, radiation therapy, and systemic drug therapy chosen by the tumour subtype: chemotherapy, HER2-targeted therapy for HER2-positive disease, and hormone (endocrine) therapy for ER/PR-positive disease. Reconstruction options are available too. Many centers hold JCI accreditation and Turkish Ministry of Health state authorization, both of which you can check yourself before you commit. The honest first step is a free case review of your pathology and imaging so the plan — and whether receptor testing is complete — is understood before you travel.
Why do ER, PR and HER2 receptor tests matter?
Because they decide the whole systemic plan. Per the NCI, breast cancers are tested for estrogen and progesterone receptors (ER/PR) and for HER2 status, and those results drive drug choice. ER/PR-positive tumours respond to hormone (endocrine) therapy such as tamoxifen or an aromatase inhibitor; HER2-positive tumours get HER2-targeted drugs such as trastuzumab added to chemotherapy; triple-negative tumours (ER, PR and HER2 all negative) rely on chemotherapy, and sometimes immunotherapy or PARP inhibitors. Receptor testing is standard, and a case review will flag whether it is already complete on your reports. This is general information, not a treatment recommendation.
Can I keep my breast (lumpectomy vs mastectomy)?
Often, yes. The NCI describes breast-conserving surgery (lumpectomy), which removes the tumour and a rim of normal tissue while keeping the breast, and mastectomy, which removes the whole breast — and for many early cancers lumpectomy followed by radiation gives outcomes comparable to mastectomy. The choice depends on tumour size relative to the breast, whether there is more than one tumour, and your own preference. Lymph nodes are checked with a sentinel node biopsy, and reconstruction can often be discussed either way. Which operation fits your case is a surgical-oncology decision, and a case review tells you what your reports do and don't yet establish.
How much does breast cancer treatment cost in Istanbul?
There is no single figure, because the cost is driven by the type of surgery (lumpectomy versus mastectomy, and whether reconstruction is done), whether radiation is used, the number of chemotherapy cycles, and whether HER2-targeted drugs or long-course hormone therapy are added — the targeted drugs are priced per cycle and can dominate the total. Istanbul typically runs well below Western-European prices for the same protocol, but every figure OncologyIstanbul™ publishes today is an illustrative placeholder pending verified partner-hospital quotes, itemized so you can check a real written quote line by line. You pay the hospital directly, never us. See the Turkey Oncology Price Index for current ranges.
Start with a free 72-hour case review
Send your pathology and imaging. Get a verified case file in your language — free, confidential, no obligation.
This page is general information, not medical advice. Medical facts are grounded in the U.S. National Cancer Institute; prices shown are illustrative placeholders pending verified partner-hospital quotes, not offers. Every cancer case is individual; assessments are based on the reports you provide and do not replace in-person examination.